Literature DB >> 9296228

Noninvasive evaluation of cardiotoxicity of 5-fluorouracil and low doses of folinic acid: a one-year follow-up study.

A M Grandi1, G Pinotti, E Morandi, P Zanzi, P Bulgheroni, L Guasti, A Bertolini, A Venco.   

Abstract

PURPOSE: To conduct a serial evaluation of the cardiac effects of antineoplastic therapy with 5-fluorouracil (5-FU) and low-dose folinic acid. PATIENTS AND METHODS: Sixteen patients with colon-rectal carcinoma, without cardiac disease, treated with 400 mg/ m2/die of 5-FU and 20 mg/m2/die of folinic acid for five days, once a month, for six months. Parameters evaluated: blood pressure, ECG, two-dimensional and digitized M-mode echocardiograms before and after the first and fifth drug administrations of the first cycle, after the fifth drug administration of the sixth cycle and six months after the treatment.
RESULTS: Blood pressure, heart rate, left ventricular (LV) diameter and LV mass index did not change; all of the patients showed a decrease in the peak shortening rate of the LV diameter index of systolic function, and of the peak lengthening rate of the LV diameter and peak thinning rate of LV posterior wall, indexes of diastolic function, with abnormal values in 11 patients at the end of treatment LV wall motion remained normal in all; two patients developed transient T wave inversion without chest pain and with normal cardiac enzymes and myocardial scintigraphy during dypiridamole stress test. Six months after the treatment all indexes of LV systolic and diastolic function had returned within the normal limits and were similar to pre-treatment values.
CONCLUSIONS: 5-FU and low-dose folinic acid treatment induced a decrease of LV systolic function and an impairment of diastolic function, that developed without symptoms and were transient and reversible.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9296228     DOI: 10.1023/a:1008263321681

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  4 in total

Review 1.  Cardiotoxicity of the antiproliferative compound fluorouracil.

Authors:  K Becker; J F Erckenbrecht; D Häussinger; T Frieling
Journal:  Drugs       Date:  1999-04       Impact factor: 9.546

2.  Reversible cardiogenic shock following 5-fluorouracil infusion.

Authors:  Charles Ferté; Carlos Gomez Roca; Yohann Loriot; Rastislav Bahleda; Cristian Moldovan; Ariel Cohen; Hassan Izzedine; Jean-Charles Soria; Stephane Ederhy
Journal:  Invest New Drugs       Date:  2009-06-05       Impact factor: 3.850

3.  Adjuvant Treatment with 5-Fluorouracil and Oxaliplatin Does Not Influence Cardiac Function, Neurovascular Control, and Physical Capacity in Patients with Colon Cancer.

Authors:  Raphaela V Groehs; Marcelo V Negrao; Ludhmila A Hajjar; Camila P Jordão; Bruna P Carvalho; Edgar Toschi-Dias; Ana C Andrade; Fabiana P Hodas; Maria J N N Alves; Adriana O Sarmento; Laura Testa; Paulo M G Hoff; Carlos E Negrao; Roberto Kalil Filho
Journal:  Oncologist       Date:  2020-08-31

4.  Cardiotoxicity of fluoropyrimidines in different schedules of administration: a prospective study.

Authors:  Christos Kosmas; Manolis S Kallistratos; Petros Kopterides; John Syrios; Helias Skopelitis; Nicolaos Mylonakis; Athanasios Karabelis; Nicolas Tsavaris
Journal:  J Cancer Res Clin Oncol       Date:  2007-07-17       Impact factor: 4.322

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.